Presentation at the American Academy of Optometry (AAOPT) 2023 showed significant improvements with CEQUA ® for topical ophthalmic use in both corneal fluorescein staining (CFS) and symptom ...
Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye. This was a phase 4, single-arm, multicenter ...
Richard Adler, MD, FACS, discusses the Switch trial which compared OTX-101 (cyclosporine ophthalmic solution 0.09%) vs cyclosporine ophthalmic emulsion 0.05% (Restasis) in patients with dry eye ...
Cequa (cyclosporine) may not be safe to administer while pregnant or breastfeeding. Certain factors, including the risks of fetal harm, may determine whether you should administer the drug during this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results